Mieke Van Acker possesses extensive experience in the life sciences and biopharmaceutical sectors, having held various leadership roles throughout a diverse career. Mieke served as Co-CEO at MyCartis from February 2018 to January 2020 and as CEO of Biogazelle from November 2019 to December 2020. Current positions include Owner of MVA-c and Board Member at MEDIPARTNER, with previous roles such as Board Member for Flandersbio and Vice President at Merck Millipore and Merck Group. Mieke's career began as a Sales Specialist at LKB Pharmacia and transitioned through various roles in prominent companies, including Waters Corporation and Millipore, achieving significant milestones in sales and business development. Mieke's academic background includes a Master's degree from KULeuven and advanced business education from Vlerick Business School and INSEAD.
This person is not in the org chart
This person is not in any teams
This person is not in any offices